← Leaderboards
Mel Ruzicka
Intralytix, Inc.
$1,797,717
Attributed
$1,797,717
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2021–22$2M$1.5M$1M$500K$0
'21
'22
Funding mix
By agency
NIH$1,797,717 · 1
By mechanism
N44$1,498,045 · 1
N43$299,672 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Artificial Intelligence”
- John E West · University Of Texas At Austin$95,166,667
- Klaus Romero · Critical Path Institute$29,190,596
- Jennifer K Balch · University Of Massachusetts Amherst$14,831,210
- Rene S. Kahn · Icahn School Of Medicine At Mount Sinai$13,240,338
- Alan James Bridge · European Molecular Biology Laboratory$8,871,376
- John Damon Chodera · Sloan-Kettering Inst Can Research$8,477,219
Research focus
Artificial IntelligenceBacterial Drug ResistanceBacteriophagesBaseClinical ApplicationGram-Negative BacteriaPreparationTherapeutic Development
Grant awards (2)
A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications$1,498,045
N44 · FY2022 · AI · contact PI
A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications$299,672
N43 · FY2021 · AI · contact PI